Drug profile · INN
desloratadine
DESLORATADINE KRKA
desloratadine (DESLORATADINE KRKA) is a histamine h1 receptor antagonist. Associated with Teva Pharma GmbH. Route of administration: oral. Current US regulatory status: approved.
Drug details — desloratadine
- US status
- approved
- Class
- Respiratory system (R01)
- Route
- ORAL
- Patents
- 2
- Programs
- 4
- Data quality
- 0.89
Quick answer
desloratadine (DESLORATADINE KRKA) is a histamine h1 receptor antagonist. Associated with Teva Pharma GmbH. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Histamine H1 receptor antagonist
Primary target: Histamine H1 receptor
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
| EMA | approved | — |
Pipeline programs
Related & competitor drugs
Related patents
Frequently asked questions
What is desloratadine?
desloratadine (DESLORATADINE KRKA) is a histamine h1 receptor antagonist. Associated with Teva Pharma GmbH. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for desloratadine?
DESLORATADINE KRKA is a marketed brand name for desloratadine. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of desloratadine?
desloratadine has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.